Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

PET/MRI for the Staging of Newly Diagnosed Prostate Cancer

Trial Profile

PET/MRI for the Staging of Newly Diagnosed Prostate Cancer

Phase of Trial: Phase 0

Latest Information Update: 20 Jun 2018

At a glance

  • Drugs 18F DCFPyL (Primary)
  • Indications Prostate cancer
  • Focus Diagnostic use
  • Most Recent Events

    • 12 Jun 2018 Status changed from not yet recruiting to recruiting.
    • 11 Apr 2018 Planned End Date changed from 20 Feb 2023 to 1 Jun 2023.
    • 11 Apr 2018 Planned primary completion date changed from 20 Jan 2023 to 1 May 2023.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top